Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug repositioning
Biotech
Mayo Clinic helps tech-enabled R&D shop nference to $60M B round
Nference thinks its platform can help identify new targets and drug combinations by corralling existing data.
Nick Paul Taylor
Jan 8, 2020 8:11am
Healx raises $56M to launch 40 rare disease R&D programs
Oct 16, 2019 3:00am
Healx reels in $10M in series A funding for work on rare diseases
Jul 27, 2018 11:17am
BTI files for $69M IPO to run trials in Alzheimer's and cancer
Feb 13, 2018 8:39am
Roivant bags AstraZeneca drug in latest bid
Oct 20, 2017 8:53am
Mayo Clinic startup raises series A round for AI-driven R&D
Jul 14, 2017 6:04am
